Synthetic Biologics, Inc News Headlines

SYN 
$1.58
*  
0.19
10.73%
Get SYN Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading SYN now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Sector Update: Health-Care Shares Higher Pre-Bell
10/22/2014 8:40:32 AM - MT Newswires


Sector Update: Health Care
10/22/2014 8:36:33 AM - MT Newswires


Synthetic Biologics To Raise About $20.7 Mln In Registered Direct Offering
10/10/2014 9:25:00 AM - RTT News


Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics
10/10/2014 8:54:00 AM - Seeking Alpha


Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog
9/16/2014 5:00:00 PM - Zacks.com


Monday Sector Laggards: Biotechnology, Application Software Stocks
9/15/2014 1:33:48 PM - BNK Invest


Synthetic Biologics Investor Conference Call; Webcast At 9:15 AM ET
9/12/2014 8:15:00 AM - RTT News


Synthetic Bio. To Present At Rodman & Renshaw Conference;Webcast At 10:25 AM ET
9/9/2014 9:25:00 AM - RTT News


Digesting The GMO Food Controversy And What It Means For Your Investment Portfolio
7/10/2014 11:33:00 AM - Seeking Alpha


Why I'm Short Synthetic Biologics After Phase II Relapsing-Remitting MS Data
5/19/2014 5:53:00 PM - Seeking Alpha


Healthcare Stocks Ending in the Red; Synthetic Biologics Rises After Outlining Trial Schedule for c. Diff Drug
5/15/2014 3:52:52 PM - MT Newswires


Sector Update: Healthcare
5/15/2014 3:52:13 PM - MT Newswires


AmpliPhi Biosciences: A Speculative Play In Biopharmaceuticals Too Compelling To Ignore
4/11/2014 9:49:00 AM - Seeking Alpha


Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster?
4/10/2014 11:06:00 AM - Seeking Alpha


OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals
3/25/2014 1:35:00 PM - Seeking Alpha


Synthetic Biologics Inc. (SYN) in Focus: Stock up 9.5% - Tale of the Tape
3/20/2014 9:04:01 AM - Zacks.com


Following The Smart Money: The Small Cap Biotech Investments Of Randal J. Kirk
3/11/2014 8:30:00 AM - Seeking Alpha


Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst
2/19/2014 7:55:00 AM - Seeking Alpha


Synthetic Biologics (SYN) Worth Watching: Stock Soars 19.8% - Tale of the Tape
2/14/2014 10:46:01 AM - Zacks.com


Synthetic Biologics (SYN) Slumps: Stock Tanks 11.4% - Tale of the Tape
1/28/2014 9:38:01 AM - Zacks.com


Synthetic Biologics (SYN) in Focus: Stock Surges 18.1% - Tale of the Tape
12/24/2013 10:18:10 AM - Zacks.com


Synthetic Biologics: Randal Kirk And A Robust Pipeline For 2014
12/23/2013 2:38:00 AM - Seeking Alpha


Four Small-Cap Growth Names with Different Value Drivers: Keay Nakae
9/20/2013 3:23:21 PM - Trefis


Synthetic Biologics' Sniper Approach To Infectious Diseases
5/29/2013 4:24:00 AM - Seeking Alpha


Genetically Modified Food Investing
4/30/2013 4:09:00 AM - Seeking Alpha